Candel Therapeutics Inc. (CADL)
7.86
0.02 (0.26%)
At close: Jan 15, 2025, 3:59 PM
7.55
-3.88%
After-hours Jan 15, 2025, 04:03 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -37.94M | -18.79M | -36.12M | -17.68M | -8.24M |
| Depreciation & Amortization | 960.00K | 778.00K | 232.00K | 91.00K | 43.00K |
| Stock-Based Compensation | 3.09M | 2.31M | 2.96M | 2.11M | 400.00K |
| Other Working Capital | -570.00K | 1.28M | -1.54M | 1.49M | 500.00K |
| Other Non-Cash Items | 169.00K | -15.78M | 76.00K | 32.00K | 2.11M |
| Deferred Income Tax | n/a | n/a | 11.51M | 4.61M | n/a |
| Change in Working Capital | -525.00K | 71.00K | -876.00K | 1.77M | 513.00K |
| Operating Cash Flow | -34.24M | -31.42M | -22.22M | -9.07M | -5.18M |
| Capital Expenditures | -457.00K | -1.30M | -1.83M | -1.48M | -159.00K |
| Acquisitions | n/a | n/a | n/a | -39.93M | -846.00K |
| Purchase of Investments | n/a | n/a | n/a | -6.00K | -39.11M |
| Sales Maturities Of Investments | n/a | n/a | n/a | 39.94M | 4.37M |
| Other Investing Acitivies | 177.00K | n/a | n/a | 39.93M | -34.74M |
| Investing Cash Flow | -280.00K | -1.30M | -1.83M | 38.45M | -35.74M |
| Debt Repayment | n/a | 19.91M | n/a | 460.00K | n/a |
| Common Stock Repurchased | -121.00K | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -121.00K | 64.00K | 465.00K | 30.00K | 44.48M |
| Financial Cash Flow | -121.00K | 19.97M | 71.80M | 490.00K | 21.98M |
| Net Cash Flow | -34.65M | -12.74M | 47.75M | 29.87M | -18.94M |
| Free Cash Flow | -34.70M | -32.72M | -24.05M | -10.55M | -5.34M |